Roman Lesyk

6.3k total citations
236 papers, 5.0k citations indexed

About

Roman Lesyk is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Roman Lesyk has authored 236 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Organic Chemistry, 47 papers in Molecular Biology and 34 papers in Pharmacology. Recurrent topics in Roman Lesyk's work include Synthesis and biological activity (154 papers), Synthesis and Characterization of Heterocyclic Compounds (70 papers) and Synthesis of heterocyclic compounds (43 papers). Roman Lesyk is often cited by papers focused on Synthesis and biological activity (154 papers), Synthesis and Characterization of Heterocyclic Compounds (70 papers) and Synthesis of heterocyclic compounds (43 papers). Roman Lesyk collaborates with scholars based in Ukraine, Poland and France. Roman Lesyk's co-authors include Borys Zimenkovsky, Dmytro Havrylyuk, Andrzej Gzella, Danylo Kaminskyy, Olexandr Vasylenko, Anna Kryshchyshyn‐Dylevych, Dmytro Atamanyuk, Lucjusz Zaprutko, Serhii Holota and Philippe Grellier and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Roman Lesyk

220 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roman Lesyk Ukraine 38 3.9k 1.1k 504 323 288 236 5.0k
Preet Mohinder Singh Bedi India 33 2.2k 0.6× 1.2k 1.1× 380 0.8× 235 0.7× 152 0.5× 125 3.8k
Mymoona Akhter India 25 2.3k 0.6× 794 0.7× 284 0.6× 392 1.2× 124 0.4× 100 3.1k
Hong‐Min Liu China 40 3.4k 0.9× 2.5k 2.2× 388 0.8× 239 0.7× 259 0.9× 247 6.0k
Marinella Roberti Italy 35 1.5k 0.4× 1.6k 1.4× 475 0.9× 284 0.9× 183 0.6× 111 3.6k
Ahmet Özdemır Türkiye 34 2.7k 0.7× 836 0.7× 433 0.9× 365 1.1× 160 0.6× 141 3.6k
Ş. Güniz Küçükgüzel Türkiye 29 3.6k 0.9× 911 0.8× 448 0.9× 331 1.0× 201 0.7× 79 4.5k
José M. Padrón Spain 31 2.2k 0.6× 1.5k 1.3× 458 0.9× 188 0.6× 365 1.3× 240 3.9k
Mohammad Shaquiquzzaman India 25 2.3k 0.6× 782 0.7× 258 0.5× 340 1.1× 105 0.4× 66 3.0k
Raj Kumar India 37 2.7k 0.7× 1.6k 1.4× 318 0.6× 229 0.7× 140 0.5× 121 4.5k
Mostafa M. Ghorab Egypt 41 3.9k 1.0× 1.7k 1.5× 304 0.6× 211 0.7× 275 1.0× 216 4.7k

Countries citing papers authored by Roman Lesyk

Since Specialization
Citations

This map shows the geographic impact of Roman Lesyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Lesyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Lesyk more than expected).

Fields of papers citing papers by Roman Lesyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Lesyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Lesyk. The network helps show where Roman Lesyk may publish in the future.

Co-authorship network of co-authors of Roman Lesyk

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Lesyk. A scholar is included among the top collaborators of Roman Lesyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Lesyk. Roman Lesyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Czarnomysy, Robert, Agnieszka Gornowicz, Olexandr Karpenko, et al.. (2025). 5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells. Cells. 14(12). 861–861.
2.
Glomb, Teresa, Olga Wesołowska, Agnieszka Wikiera, et al.. (2025). New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling. ChemMedChem. 20(7). e202400687–e202400687. 1 indexed citations
3.
Lesyk, Roman, et al.. (2024). Structure, unique biological properties, and mechanisms of action of transforming growth factor β. Bioorganic Chemistry. 150. 107611–107611. 11 indexed citations
4.
Skupin-Mrugalska, Paulina, et al.. (2024). Introducing bromine to the molecular structure as a strategy for drug design. Journal of Medical Science. 93(3). e1128–e1128. 9 indexed citations
5.
Klyuchivska, Olga, et al.. (2024). Evaluation of thiopyrano[2,3‐d]thiazole derivatives as potential anticonvulsant agents. Archiv der Pharmazie. 357(10). e2400357–e2400357. 1 indexed citations
6.
7.
Skóra, Bartosz, et al.. (2024). Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines. Cells. 13(12). 1007–1007. 2 indexed citations
8.
Chen, Yiliang, Xiaolong Ding, Liang Zhang, et al.. (2023). Design, synthesis, and anticancer evaluation of nitrobenzoxadiazole-piperazine hybrids as potent pro-apoptotic agents. Tetrahedron. 138. 133393–133393. 4 indexed citations
9.
Szewczyk-Roszczenko, Olga Klaudia, Piotr Roszczenko, Anna Shmakova, et al.. (2023). The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications. Cells. 12(18). 2312–2312. 29 indexed citations
10.
Skóra, Bartosz, Anna Lewińska, Anna Kryshchyshyn‐Dylevych, et al.. (2022). Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives. Molecules. 27(3). 894–894. 27 indexed citations
11.
Roszczenko, Piotr, Serhii Holota, Olga Klaudia Szewczyk-Roszczenko, et al.. (2022). 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. International Journal of Molecular Sciences. 23(21). 13135–13135. 49 indexed citations
12.
Lozynskyi, Andrii, et al.. (2021). Psychotropic properties of a potential anticonvulsant of 5-[(Z)-(4-nitrobenzylidene)]-2- (thiazol-2-ylimino)-4-thiazolidinone. News of pharmacy. 96–103. 2 indexed citations
13.
14.
Holota, Serhii, et al.. (2021). N-(3-Cyano-4,5,6,7-tetrahydrobenzothiophen-2-yl)-2-[[5-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide. SHILAP Revista de lepidopterología. 2021(2). M1211–M1211. 5 indexed citations
15.
Holota, Serhii, et al.. (2021). 5-[4-(tert-Butyl)cyclohexylidene]-2-thioxothiazolidin-4-one. SHILAP Revista de lepidopterología. 2021(4). M1281–M1281. 1 indexed citations
16.
Lozynskyi, Andrii, et al.. (2020). Synthesis and Biological Activity Evaluation of Polyfunctionalized Anthraquinonehydrazones. Letters in Drug Design & Discovery. 18(2). 199–209. 6 indexed citations
17.
Szychowski, Konrad A., Bartosz Skóra, Anna Kryshchyshyn‐Dylevych, et al.. (2020). Induction of Cyp450 enzymes by 4-thiazolidinone-based derivatives in 3T3-L1 cells in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(5). 915–927. 11 indexed citations
18.
Kryshchyshyn‐Dylevych, Anna, et al.. (2019). Thiazolidinone/thiazole based hybrids – New class of antitrypanosomal agents. European Journal of Medicinal Chemistry. 174. 292–308. 54 indexed citations
19.
Finiuk, Nataliya, Danylo Kaminskyy, Dmytro Havrylyuk, et al.. (2016). 5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells. European Journal of Medicinal Chemistry. 117. 33–46. 66 indexed citations
20.
Kryshchyshyn‐Dylevych, Anna, Danylo Kaminskyy, Philippe Grellier, & Roman Lesyk. (2014). Trends in research of antitrypanosomal agents among synthetic heterocycles. European Journal of Medicinal Chemistry. 85. 51–64. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Preet Mohinder Singh Bedi Breakdown of academic impact, for papers by Mymoona Akhter Breakdown of academic impact, for papers by Hong‐Min Liu Breakdown of academic impact, for papers by Marinella Roberti Breakdown of academic impact, for papers by Ahmet Özdemır Breakdown of academic impact, for papers by Ş. Güniz Küçükgüzel Breakdown of academic impact, for papers by José M. Padrón Breakdown of academic impact, for papers by Mohammad Shaquiquzzaman Breakdown of academic impact, for papers by Raj Kumar Breakdown of academic impact, for papers by Mostafa M. Ghorab
Rankless by CCL
2026